Sunday, 20 September 2026European Markets

SELECTIRENTE And ARGAN Have A High Dividend Yield And Return On Equity In The Real Estate Sector.

Loading stream...

(vianews) - selectirente (seler.pa) is among this list of stock assets with the highest dividend rate and return on equity on the real estate sector.

financial asset price forward dividend yield return on equity
selectirente (seler.pa) €88.00 4.73% 5.87%
argan (arg.pa) €77.10 4.07% 4.67%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. selectirente (seler.pa)

4.73% forward dividend yield and 5.87% return on equity

selectirente is a public real estate fund managed by sofidy. it invests in city center and suburb commercial properties, which should be located close to shopping malls. it primarily acquires properties in france. as of march 29, 2019, selectirente operates as a subsidiary of tikehau capital.

earnings per share

as for profitability, selectirente has a trailing twelve months eps of €2.32.

pe ratio

selectirente has a trailing twelve months price to earnings ratio of 37.93. meaning, the purchaser of the share is investing €37.93 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.87%.

more news about selectirente.

2. argan (arg.pa)

4.07% forward dividend yield and 4.67% return on equity

argan sa engages in designing, building, developing, owning, leasing, and managing logistical platforms in france. it is also involved in the development and management of land. the company's real estate property consists of a total area of 806,000 square meters. it serves shippers and logistics companies. the company was founded in 1993 and is based in neuilly sur seine, france.

earnings per share

as for profitability, argan has a trailing twelve months eps of €4.

pe ratio

argan has a trailing twelve months price to earnings ratio of 19.27. meaning, the purchaser of the share is investing €19.27 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.67%.

dividend yield

as stated by morningstar, inc., the next dividend payment is on mar 27, 2024, the estimated forward annual dividend rate is 3.15 and the estimated forward annual dividend yield is 4.07%.

moving average

argan's worth is higher than its 50-day moving average of €76.08 and below its 200-day moving average of €77.19.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, argan's stock is considered to be overbought (>=80).

more news about argan.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com